Heartflow (HTFL) EBT Margin (2024 - 2025)
Heartflow's quarterly EBT Margin came in at 175.5% in Q4 2025, down 591.0% year-on-year from 35.74% in Q4 2024, and up 259.79% quarter-over-quarter from 109.83% in Q3 2025.
Heartflow has reported EBT Margin for 2 years, with the latest figure at 175.5% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin fell 591.0% year-over-year to 175.5%; the trailing twelve-month figure through Dec 2025 stood at 51.62% (changed N/A YoY), and the FY2025 full-year result was 3.46%, down 349.0% from the prior year.
- EBT Margin for Q4 2025 stood at 175.5%, up from 109.83% in the prior quarter.
- The five-year high for EBT Margin was 181.41% in Q4 2024, with the low at 109.83% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 37.99% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 2.29% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 26.06% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 19.72% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 22.10% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 19.06% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -8.52% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 1.54% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 5.46% |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn | 175.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 175.50% |
| Sep 30, 2025 | -109.83% |
| Jun 30, 2025 | -21.04% |
| Dec 31, 2024 | 181.41% |
| Sep 30, 2024 | -58.12% |
| Jun 30, 2024 | -74.90% |